Federal Trade Commission (FTC) news and information

Actavis has agreed to sell the rights to three generic oral contraceptives and one other drug to resolve the government's antitrust concerns with the drugmaker's $8.5 billion acquisition of Warner Chilcott.
FULL STORY »

BOISE, Idaho—In a case that will help define how antitrust regulators view hospital acquisitions of doctor practices for years to come, the Federal Trade Commission is scheduled to open a four-week civil trial in Idaho this week in an attempt to unwind the purchase of the state’s...
FULL STORY »

The Federal Trade Commission has thrown a few wet blankets in the go-go world of healthcare corporate transactions in recent years, in the form of litigation to block mergers. But the agency's new director says most of the FTC's enforcement of antitrust laws actually happens in the less-discussed...
FULL STORY »

With the Federal Trade Commission showing renewed interest in policing mergers among healthcare providers, Chairwoman Edith Ramirez appointed noted healthcare economist Martin Gaynor to lead the commission's Economics Bureau.
FULL STORY »

With the Federal Trade Commission showing renewed interest in policing mergers among healthcare providers, the agency's new chairwoman has appointed a noted Pittsburgh healthcare economist who studies hospital consolidation to lead the commission's Economics Bureau.
FULL STORY »

The Federal Trade Commission on Thursday accused a small Atlanta-based medical lab that specializes in cancer detection of not doing enough to protect its patients' online records, resulting in the leak of Social Security numbers and birth dates of more than 9,000 consumers.
FULL STORY »

The Federal Trade Commission may have won a battle, but it lost the war over Phoebe Putney Health System's expansion in southwestern Georgia.
FULL STORY »

“The Federal Trade Commission has been battling for years to end a devious tactic used by some drug companies to pay competitors to delay putting cheaper generic versions of their brand-name drugs on the market. The tactic, known as pay-for-delay, results in higher costs for consumers.
FULL STORY »

With the reform law casting intense scrutiny on costs and what drives them, the American Hospital Association wants to deflect the notion that hospital consolidation is a significant factor.
FULL STORY »

As hospital mergers undergo increased regulatory scrutiny, the American Hospital Association is firing back with a new report suggesting most transactions are not anticompetitive.
FULL STORY »